Gabor Erdosi 🧩📄📊🧭 Profile picture
Dec 13, 2020 24 tweets 9 min read Read on X
What a coincidence
“The binding epitope on S harbors a sequence motif unique to SARS-CoV-2 (not present in other SARS-related coronaviruses), which is highly similar in both sequence and structure to the bacterial superantigen staphylococcal enterotoxin B”
pnas.org/content/117/41… Image
Now, this story keeps unfolding.
“the trimeric spike protein of SARS-CoV-2 could bind to TLR4 directly and robustly activate downstream signaling in monocytes and neutrophils.” Via MyD88 and NFκB
See how MyD88 activation is THE problematic pathway, especially when amplified by elevated LPS exposure. I.e. by metabolic diseases.
How the two pathways join at this signaling node
👇🏻👇🏻👇🏻
journals.sagepub.com/doi/10.1177/17…
“the most profound disturbances including a prominent neutrophil hyperactivation signature and monocytes with anti-inflammatory features. We further demonstrate that emergency myelopoiesis is a prominent feature of fatal COVID-19.”
Monocytes featuring trained innate immunity?
Evidence that this may in fact work the same way in practice!
I can hardly wait for in vivo confirmation.
“an anti-SEB monoclonal antibody (mAb), 6D3, can bind this viral motif, and in particular its PRRA insert, to inhibit infection by blocking the access of host cell proteases, TMPRSS2 or furin, to the cleavage site.”
I was about to abandon this thread until in vivo evidence emerges, extending the separate thread on TLR4, but then I found this… There’s convergence/amplification. And of course the visceral fat connection (LPS ⇨ TLR4).
pubmed.ncbi.nlm.nih.gov/15504761/
Deletion of the “newly acquired” furin cleavage site, which appears to be part of a SEB motif as well, results in attenuated disease, but the mutant still confers protection against wild SARS-CoV-2 infection.
Somebody should find the TLR4 binding site, too
nature.com/articles/s4158…
The spike protein has characteristics that keep amazing me. This study shows that it binds and aggregates bacterial lipopolysaccharide, exacerbating (innate, TLR4) inflammatory signaling.
academic.oup.com/jmcb/advance-a…
Welcome to the land of MyD88 signaling & extreme peptide mimicry.
"cytokines that activate the NF-kB pathway can induce Activin A and its downstream marker, FLRG. Patients with Activin A/FLRG above the sample median were 2.6/2.9 times more likely to die" biorxiv.org/content/10.110…
Periodontal disease could make one prone to severe COVID-19/death via the same overstimulated pathways.
Recent findings (H/T @mbiranek) efp.org/news-events/ne…
Pathway studies onlinelibrary.wiley.com/doi/10.1111/od…
ejh.it/index.php/ejh/…
Not only TLR4: “N protein activates endothelial cells via TLR2-mediated NF-κB and MAPK signal pathways.” Again, other CoV NPs do not activate this pathway… another novel feature.
Note that abamectin❗️also blocked this action.
biorxiv.org/content/10.110…
“S protein triggers inflammation via activation of the NF-κB pathway in a MyD88-dependent manner. Further, such an activation of the NF-κB pathway is abrogated in Tlr2-deficient macrophages. …administration of S protein induces IL-6, TNF-α, and IL-1β” biorxiv.org/content/10.110…
“SARS-CoV-2 spike proteins bind heparan sulfate and activate the alternative complement pathway on cell surfaces.”
“the SARS-CoV-2 spike protein (subunit 1 and 2), but not the N protein, directly activates the alternative pathway of complement (APC).”
ashpublications.org/blood/article/…
In case anybody lacks understanding about the link to metabolic diseases, let’s tie up the thread from the other end:
“In this review, we present evidence for a pivotal role of TLR-induced inflammation in both obesity and MetS”
academic.oup.com/jcem/article/9…
“Here, we characterized the TCR repertoire of MIS-C patients and found a profound expansion of TCR Beta Variable gene (TRBV)11-2. Furthermore, TRBV11-2 skewing was remarkably correlated with MIS-C severity and serum cytokine levels.”
H/t @BillyBostickson
biorxiv.org/content/10.110…
Peculiar features of the virus keep emerging.
“factor Xa and thrombin can also directly cleave SARS-CoV-2 spike, enhancing viral entry.
We propose a model of positive feedback whereby infection-induced hypercoagulation exacerbates SARS-CoV-2 infectivity. biorxiv.org/content/10.110…
🧐 “a striking difference was observed in the distribution of prion-like domains in the spike protein, since SARS-CoV-2 was the only coronavirus with a prion-like domain found in the receptor-binding domain of the S1 region of the spike protein.” preprints.org/manuscript/202…
Note the signaling pathways implicated in inflammaging and how the virus (mostly the spike glycoprotein) overstimulates precisely the same inflammatory processes. The collision of aging societies, widespread metabolic diseases, and fine tuned viral fragments.
Supporting evidence in a human cohort.
COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis doi.org/10.3346/jkms.2…
“we identified several C-type lectins and Tweety family member 2 as glycan-dependent binding partners of the SARS-CoV-2 spike. …their engagement with virus induced robust proinflammatory responses in myeloid cells that correlated with COVID-19 severity.”
cell.com/immunity/fullt…
The envelope protein binds TLR2, and its blockade results in attenuation of disease.
SARS-CoV-2 binds to human epithelial cells and causes permeability.

SARS-CoV-2 uses major endothelial integrin αvβ3 to cause vascular dysregulation in-vitro during COVID-19
journals.plos.org/plosone/articl… Image
“the integrin-binding tripeptide RGD induced the nuclear translocation of NF-κB and enhanced the expression of leukocyte adhesion molecules VCAM1 and ICAM1, the adhesion of peripheral blood leukocytes, and the permeability of the monolayer.”
biorxiv.org/content/10.110…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Gabor Erdosi 🧩📄📊🧭

Gabor Erdosi 🧩📄📊🧭 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @gerdosi

Feb 18, 2023
Here I was called a COVID denier (what is that?), even though almost everything I stood for has been very close to reality since about March 2020. In fact, the only thing I was wrong about was the real world CFR of the virus. Back then I didn’t understand that poor management…
…was responsible for many deaths. Too early and unnecessary use of ventilators, too early and too high dose use of dexamethasone, remdesivir administration in hospitalized patients, avoidance of adding cheap and very low risk prophylactics, etc.
I only recognized these later.
I do remember when ventilator use was cut in half from one week to the other, following a protocol change in May 2020. Then I read this review from 2017 & realized that a lot more had been known about disease treatment than what was happening in hospitals. How could this happen?
Read 5 tweets
Feb 15, 2022
Dude either has no clue about what ‘immunity’ is, or has a very narrow tunnel view of it. Alternatively he’s deliberately spreading misinformation here.
NB, more typical courses have been:
Infection with Wuhan + Omicron
Infection with Alpha + Omicron
Infection with Wuhan + Delta + Omicron
Etc.
Guess how these typical scenarios fair against vaccination + Omicron? Yep, you’re absolutely right.
Immunology noobs question my assessments above.
Please consider that the study only looked at systemic humoral immunity and Ab binding to the spike protein. Then think about all the layers of immunity omitted from the analysis, e.g. innate, mucosal, T cells, to all antigens, etc.
Read 4 tweets
Dec 20, 2021
If you’re heading to the hospital with COVID make sure to declare that you’re allergic to remdesivir. It’s ineffective anyway.

Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease 2019: a retrospective case–noncase study kidney-international.org/article/S0085-… Text Shot: Our findings, ba...
While remdesivir is still touted as ‘safe and effecrive’ in the COVID response of many countries, public health officials start removing health insurance reimbursement for vitamins and minerals due to lack of efficacy shown… Could you make this up? businessinsider.co.za/medical-scheme…
My sad personal experience echoes this. theepochtimes.com/controversial-…
Read 4 tweets
Dec 10, 2021
‘Pandemic’ (changed by WHO in 2009)
‘Vaccine’ (changed by CDC in 2021, where kefir or vitamin D now fully qualify)
‘Peer reviewed’ (clueless people repeat it as mantra)
‘Breakthrough infection’ (if there’s robust immunity
‘T cells’ (ignored and ridiculed until Omicron appeared)
Oops, some editing issue at ‘peer reviewed’
If there’s robust immunity infecfion doesn’t occur. It only does if immunization was unsuccessful.
I think that we can safely add
‘hybrid immunity’
when it’s used as some superhuman state instead of natural immunity with repeated pathogen/antigen exposure.
Read 4 tweets
Dec 6, 2021
A recently developed method, that expresses full spike trimers, enables more accurate measurement of binding IgG1 antibodies. Quite a few interesting results in this study.
First of all, the second dose of mRNA vaccines adds very little extra binding. medrxiv.org/content/10.110…
More importantly, the absolute increase in Delta variant binding antibodies following administration of the 2nd dose to previously infected people is limited to a small subset of adults. At the same time, the relative number of Delta binding Ab to non-binding (old Wuhan) Ab is…
…terribly low. What’s the use of that thick soup of sky high antibodies then? Triggering autoimmunity? 🤔
The authors are not impressed either, although expected such results from shotgun injecting the same antigen, leaving no time for maturation.
Read 4 tweets
Oct 11, 2021
Let me strip the unnecessary narrative out of this otherwise nice study/abstract to get a clear picture. Short thread 🧵

Anti-SARS-CoV-2 receptor binding domain antibody evolution after mRNA vaccination
nature.com/articles/s4158…
How infection elicits broad protection
“SARS-CoV-2 infection produces B cell responses that continue to evolve for at least one year. During that time, memory B cells express increasingly broad and potent antibodies that are resistant to mutations found in variants of concern”
Following vaccination
“Between prime and boost, memory B cells produce antibodies that evolve increased neutralizing activity, but there is no further increase in potency or breadth thereafter.”
= the booster is too close to the priming dose and prevents affinity maturation.
Read 8 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(